NCT03203213

Brief Summary

Poisoning by psychoactive substances is increasingly common in Europe and can be responsible for deaths. These substances, also called "festive drugs", circulate among other places in festive gatherings (night clubs, concerts, free music, feria, etc.). The main objective of this study is to determine the molecules that circulate in festive events in Aquitaine, in order to implement prevention actions by looking at whether the circulating substances vary with the style of event.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 27, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 29, 2017

Completed
1 day until next milestone

Study Start

First participant enrolled

June 30, 2017

Completed
3 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 3, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 3, 2017

Completed
Last Updated

July 17, 2017

Status Verified

July 1, 2017

Enrollment Period

3 days

First QC Date

June 27, 2017

Last Update Submit

July 12, 2017

Conditions

Keywords

PoisoningPsychoactive substances

Outcome Measures

Primary Outcomes (1)

  • Number of patients who have consumed new psychoactive substances

    Number of patients who have consumed new psychoactive substances

    baseline

Secondary Outcomes (4)

  • number of toxidomas observed clinically

    Baseline

  • number of patients who have previously used new psychoactive substances (hair, urine

    Baseline

  • number of classes of new psychoactive substances found in the analyzes

    baseline

  • severity evaluated secondarily from the clinical data sheets and according to poisoning severity score

    baseline

Study Arms (1)

Interventional arm

EXPERIMENTAL

* Sampling of a few additional drops of blood and sending this sample for analysis and identification of a possible toxic cause by psychoactive substance in relation to the clinical picture presented by the patient * Oriented hair removal is also carried out if possible (small wick cut and not torn the size of a pencil mine of paper taken at the level of the occipital region). This technique has been used many times, and evaluates the previous consumption (memory consumption) * A urine sample is taken if possible.

Procedure: Sampling of a few drops of blood, lock of hair and urine

Interventions

Sampling of a few additional drops of blood to deposit them on blotting paper (DBS: Dried Blood Spot) ad hoc and to send this sample for analysis and identification of a possible toxic cause by psychoactive substance in relation to the clinical picture presented by the patient. An oriented capillary sampling is also performed if possible. Similarly a urine sample is taken if possible.

Interventional arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Any patient admitted to the Emergency Medical Post with neurological and / or behavioral disorders:
  • agitated at the time of admission to the PMA or during surveillance at the LDC
  • and who will say (or for whom his entourage will say that he has) consumed psychoactive substances
  • or who will be unable to say that they have taken a psychoactive substance and for which no other etiology is evident
  • and / or for which the seriousness of the case necessitates admission to the emergency or intensive care, whether or not the physician is aware of a psychoactive substance (and in the absence of an obvious etiology)
  • and / or if the PMA physician considers that analytical research is needed for further care
  • Oral Express Consent
  • any patient who is in possession of an identity document proving his / her majority (over 18 years).

You may not qualify if:

  • Refusal of the patient to take a sample, or to participate in the study
  • Minors (under 18 years of age)
  • Pregnant women
  • Breastfeeding women
  • Patient who can not prove his / her age by the production of an identity document.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hopital Pellegrin

Bordeaux, 33076, France

Location

MeSH Terms

Conditions

Poisoning

Interventions

Urination

Condition Hierarchy (Ancestors)

Chemically-Induced Disorders

Intervention Hierarchy (Ancestors)

Urinary Tract Physiological PhenomenaReproductive and Urinary Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: monocentric study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 27, 2017

First Posted

June 29, 2017

Study Start

June 30, 2017

Primary Completion

July 3, 2017

Study Completion

July 3, 2017

Last Updated

July 17, 2017

Record last verified: 2017-07

Data Sharing

IPD Sharing
Will not share

Locations